CD44-DT regulates p21-dependent senescence via interacting with AR-PCNA complex, revealing a therapeutic vulnerability to chimeric ncRNA-mediated AR degradation in prostate cancer
Aberrant androgen receptor (AR) signaling driven by androgens plays a critical role in prostate cancer (PCa) progression. Interestingly, bipolar androgen therapy (BAT), a novel therapeutic strategy with cycles between near-castrate and supraphysiological androgen levels (SAL), suppresses PCa growth. SAL induces cellular senescence in various PCa models mediated by the AR, activation of AKT…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.